Pharmaceutical and life sciences companies will have big headaches to deal with this year. Global regulatory compliance, effective cost management and loss of patent exclusivity pose serious supply chain threats. While it may not solve all the problems, there is a way to ease some of the pain. It’s called supply chain resiliency.